BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12651893)

  • 1. A model of repression: CTD analogs and PIE-1 inhibit transcriptional elongation by P-TEFb.
    Zhang F; Barboric M; Blackwell TK; Peterlin BM
    Genes Dev; 2003 Mar; 17(6):748-58. PubMed ID: 12651893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activity and substrate recognition of cyclin T2 from P-TEFb.
    Kurosu T; Zhang F; Peterlin BM
    Gene; 2004 Dec; 343(1):173-9. PubMed ID: 15563843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II.
    Lu H; Yu D; Hansen AS; Ganguly S; Liu R; Heckert A; Darzacq X; Zhou Q
    Nature; 2018 Jun; 558(7709):318-323. PubMed ID: 29849146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic activity of Cdk9 is required for nuclear co-localization of the Cdk9/cyclin T1 (P-TEFb) complex.
    Napolitano G; Majello B; Lania L
    J Cell Physiol; 2003 Oct; 197(1):1-7. PubMed ID: 12942536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo.
    Shim EY; Walker AK; Shi Y; Blackwell TK
    Genes Dev; 2002 Aug; 16(16):2135-46. PubMed ID: 12183367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro.
    Wada T; Takagi T; Yamaguchi Y; Watanabe D; Handa H
    EMBO J; 1998 Dec; 17(24):7395-403. PubMed ID: 9857195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA.
    Lin X; Taube R; Fujinaga K; Peterlin BM
    J Biol Chem; 2002 May; 277(19):16873-8. PubMed ID: 11884399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.
    Taube R; Lin X; Irwin D; Fujinaga K; Peterlin BM
    Mol Cell Biol; 2002 Jan; 22(1):321-31. PubMed ID: 11739744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.
    Zhou M; Huang K; Jung KJ; Cho WK; Klase Z; Kashanchi F; Pise-Masison CA; Brady JN
    J Virol; 2009 Jan; 83(2):1036-44. PubMed ID: 18971272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The growth factor granulin interacts with cyclin T1 and modulates P-TEFb-dependent transcription.
    Hoque M; Young TM; Lee CG; Serrero G; Mathews MB; Pe'ery T
    Mol Cell Biol; 2003 Mar; 23(5):1688-702. PubMed ID: 12588988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
    Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-TEFb-mediated phosphorylation of hSpt5 C-terminal repeats is critical for processive transcription elongation.
    Yamada T; Yamaguchi Y; Inukai N; Okamoto S; Mura T; Handa H
    Mol Cell; 2006 Jan; 21(2):227-37. PubMed ID: 16427012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.
    Zhou M; Halanski MA; Radonovich MF; Kashanchi F; Peng J; Price DH; Brady JN
    Mol Cell Biol; 2000 Jul; 20(14):5077-86. PubMed ID: 10866664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domains in the SPT5 protein that modulate its transcriptional regulatory properties.
    Ivanov D; Kwak YT; Guo J; Gaynor RB
    Mol Cell Biol; 2000 May; 20(9):2970-83. PubMed ID: 10757782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II.
    Napolitano G; Majello B; Licciardo P; Giordano A; Lania L
    Gene; 2000 Aug; 254(1-2):139-45. PubMed ID: 10974544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis.
    Kanazawa S; Soucek L; Evan G; Okamoto T; Peterlin BM
    Oncogene; 2003 Aug; 22(36):5707-11. PubMed ID: 12944920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription.
    Zhou M; Nekhai S; Bharucha DC; Kumar A; Ge H; Price DH; Egly JM; Brady JN
    J Biol Chem; 2001 Nov; 276(48):44633-40. PubMed ID: 11572868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of the C-terminal domain of RNA polymerase II plays central roles in the integrated events of eucaryotic gene expression.
    Hirose Y; Ohkuma Y
    J Biochem; 2007 May; 141(5):601-8. PubMed ID: 17405796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between the aryl hydrocarbon receptor and P-TEFb. Sequential recruitment of transcription factors and differential phosphorylation of C-terminal domain of RNA polymerase II at cyp1a1 promoter.
    Tian Y; Ke S; Chen M; Sheng T
    J Biol Chem; 2003 Nov; 278(45):44041-8. PubMed ID: 12917420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular control of gene expression by T-type cyclin/CDK9 complexes.
    Garriga J; Graña X
    Gene; 2004 Aug; 337():15-23. PubMed ID: 15276198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.